Tyrosine kinase inhibitors in the treatment of metastatic renal cell carcinoma

Date
2020-01-01
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Description
Subject(s)
tyrosine kinase inhibitors, metastatic renal cell carcinoma, sunitinib, pazopanib, cabozantinib, immunotherapy, prognostic group, line of treatment
Citation
Item identifier
https://dspace.tul.cz/handle/15240/158706
ISSN
ISBN
Collections